PROGRESSA SR 300
COMPOSITION : Each sustained-release tablet contains Natural Micronised Progesterone 300 mg.
Product Description
PROGRESSA-300SR Tablets contain Natural Micronised Progesterone 300 mg in a sustained-release oral formulation. Progesterone is a naturally occurring female reproductive hormone involved in regulating the menstrual cycle and supporting the endometrium.
The product is used in selected progesterone-related gynecological and reproductive-health conditions, according to the prescribing healthcare professional’s assessment.
PROGRESSA-300SR is supplied in a 10 × 1 × 10 Alu-Alu blister pack containing 100 tablets under the OBIGYN division.
Therapeutic Uses
Micronised progesterone may be prescribed for selected conditions associated with progesterone deficiency or inadequate progesterone activity, depending on the approved indication.
Potential clinical applications can include selected:
- Menstrual-cycle disorders
- Luteal-phase-related conditions
- Progesterone supplementation in assisted reproductive settings
- Other progesterone-related gynecological conditions
NOTE : The exact indication, route, dose and duration should be determined by the prescribing healthcare professional.
